LOW-VOLUME · SEX-BALANCED

bempedoic acid Side Effects

bempedoic acid (also sold as Nexletol) is a LOW-VOLUME FAERS extract #455 of 524 by FAERS report count. Still opens on SEX-BALANCED: 63% of sex-coded reports are female (1,103 F / 645 M).

Data updated 2026-05-15

2,157
FAERS reports

Thinner FAERS book - still a temporal association ledger, not proof of cause. Methodology.

bempedoic acid reporting skew - 63% of sex-coded reports are female (1,103 F / 645 M). Volume band LOW-VOLUME #455 of 524 by FAERS report count; caseload SIGNAL.

Thinner FAERS extract for bempedoic acid (Nexletol) (2,157 reports #455 of 524 by FAERS report count). 63% of sex-coded reports are female (1,103 F / 645 M). Sparse books still carry named reaction rows when present; not medical advice.

Counts from the openFDA FAERS extract (2018–2025). Stamps SIGNAL · DEATH-RARE · HOSP-LIGHT · SEX-BALANCED.

MYALGIA leads 335 of 2,157 reports

MYALGIA
335
ARTHRALGIA
214
MUSCLE SPASMS
153
PAIN IN EXTREMITY
135
NAUSEA
130
DIZZINESS
116
FATIGUE
111
HEADACHE
105
DIARRHOEA
97
BLOOD CREATINE PHOSPHOKINASE INCREASED
78
BACK PAIN
69
MUSCULAR WEAKNESS
66
GOUT
65
PAIN
65
DYSPNOEA
64
MALAISE
64
RASH
64
ABDOMINAL PAIN UPPER
58
ABDOMINAL DISCOMFORT
53

Who reports · age peak 65-74 (SEX-BALANCED)

Sex coding · SEX-BALANCED

Female 1,103 (63%)
Male 645 (37%)

Age peak 65-74 (435 reports)

0-17 28 (2%)
18-44 42 (4%)
45-64 359 (31%)
65-74 435 (37%)
75+ 310 (26%)

FAERS filings rising toward 2025

18
19
20
21
22
23
24
25

Reactions in Death Reports

Death is rare in this extract (16 / 2,157). Co-reported reactions in that thin subset:

Reaction Reports
DEATH 13
PAIN IN EXTREMITY 2
ASTHENIA 1
BRONCHIAL CARCINOMA 1
CARDIAC FAILURE 1
CARDIOVASCULAR DISORDER 1
CEREBRAL HAEMORRHAGE 1
CONSTIPATION 1
CYTOPENIA 1
DEHYDRATION 1
DIARRHOEA 1
DISEASE PROGRESSION 1
DISTURBANCE IN ATTENTION 1
DRUG INTERACTION 1
FALL 1
FATIGUE 1
GENERAL PHYSICAL HEALTH DETERIORATION 1
HEAD INJURY 1
HODGKIN^S DISEASE 1

Reactions in Hospitalization Reports

Hospitalization is lighter here (188). Reactions in that subset:

Reaction Reports
MYALGIA 36
BLOOD PRESSURE INCREASED 25
DIARRHOEA 21
NAUSEA 18
PALPITATIONS 18
MUSCULAR WEAKNESS 17
ASTHENIA 16
DEPRESSION 16
BLOOD CREATINE PHOSPHOKINASE INCREASED 15
RHABDOMYOLYSIS 15
ASPARTATE AMINOTRANSFERASE INCREASED 13
DIZZINESS 13
PAIN IN EXTREMITY 13
ARTHRALGIA 12
GAMMA-GLUTAMYLTRANSFERASE INCREASED 12
MYOGLOBIN BLOOD INCREASED 12
QUADRIPARESIS 12
HEADACHE 11
ACUTE KIDNEY INJURY 10
DYSPNOEA 9
How to read bempedoic acid FAERS figures (SIGNAL · DEATH-RARE · HOSP-LIGHT)

FAERS holds 2,157 voluntary reports linked to bempedoic acid (Nexletol), 2018-2025. Death is listed on 16 (0.7%). Hospitalization appears on 188 (8.7%). Top co-reported indication: Product Used For Unknown Indication.

Sparse extract - named reactions and SEX-BALANCED skew still differ by drug; not a complete safety profile.

Read with bempedoic acid

Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-RARE · HOSP-LIGHT stamps.